Impact of the COVID-19 pandemic on antidepressant consumption in the Central region of Portugal: interrupted time series

被引:0
作者
Negrao, Luciana G. [1 ]
Coelho, Catarina [2 ]
Castel-Branco, M. Margarida [1 ,3 ]
Figueiredo, Isabel V. [1 ,3 ]
Fernandez-Llimos, Fernando [4 ,5 ]
机构
[1] Univ Coimbra, Fac Pharm, Pharmacol & Pharmaceut Care Lab, Coimbra, Portugal
[2] IP ARSC, Adm Reg Saude Ctr, Coimbra, Portugal
[3] Coimbra Inst Clin & Biomed Res iCBR, Coimbra, Portugal
[4] Univ Porto, Fac Pharm, Dept Drug Sci, Lab Pharmacol, Jorge Viterbo Ferreira 228, P-4050313 Porto, Portugal
[5] Appl Mol Biosci Unit UCIBIO, Porto, Portugal
关键词
COVID-19; Interrupted time series analysis; Antidepressive agents; Drug utilization; Pharmacoepidemiology; DESIGNS; HEALTH;
D O I
10.1007/s00127-024-02731-0
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
PurposeTo evaluate the impact of the pandemic on the consumption of antidepressive agents in Central Portugal.MethodsTo estimate the causal effect of the pandemic an interrupted time series analysis was conducted. Data of antidepressant drugs monthly dispensed in community pharmacies between Jan-2010 and Dec-2021 were provided by the regional Health Administration. Anti-Parkinson dopaminergic agents and statins, theoretically not influenced by COVID-19 pandemics, were used as comparator series. The number of packages was converted into defined daily doses and presented as defined daily doses/1000 inhabitants/day. A Bayesian structural time-series model with CausalImpact on R/RStudio was used to predict the counterfactual. Analyses with different geographical granularity (9 sub-regions and 78 municipalities) were performed.ResultsWhen compared to counterfactual, regional consumption non-significantly increased after the pandemic declaration, with a relative effect of + 1.30% [95%CI -1.6%:4.2%]. When increasing the granularity, differences appeared between sub-region with significant increases in Baixo Mondego + 6.5% [1.4%:11.0%], Guarda + 4.4% [1.1%:7.7%] or Cova da Beira + 4.1% [0.17%:8.3%], but non-significant variation in the remaining 6 sub-regions. Differences are more obvious at municipality level, ranging from increases of + 37.00% [32.00%:42.00%] to decreases of -11.00% [-17.00%:-4.20%]. Relative impact positively correlated with percentage of elderly in the municipality (r = 0.301; p = 0.007), and negatively with population density (r=-0.243; p = 0.032). No other predicting variables were found.ConclusionAntidepressant consumption suffered very slight variations at regional level after the COVID-19 pandemic declaration. Analysis with higher granularity allowed identifying municipalities with higher impact (increase or decrease). The absence of clear association patterns suggests other causal hypotheses of the differences.
引用
收藏
页码:621 / 629
页数:9
相关论文
共 34 条
[1]   Implications of a defined daily dose fixed database for drug utilization research studies: The case of statins in Portugal [J].
Abrantes, Catarina ;
Tonin, Fernanda S. ;
Reis-Pardal, Joana ;
Castel-Branco, Margarida ;
Furtado, Claudia ;
Figueiredo, Isabel V. ;
Fernandez-Llimos, Fernando .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (09) :3542-3549
[2]  
acss, MINISTRY HLTH ANN RE
[3]   The Impact of the COVID-19 Pandemic on Mental Health [J].
Afonso, Pedro .
ACTA MEDICA PORTUGUESA, 2020, 33 (05) :356-357
[4]  
[Anonymous], CONSELHO NACIONAL DE SAUDE - Resolucao 196 de 1996
[5]  
[Anonymous], Mental Health Atlas 2020 Country Profile: Portugal
[6]   INFERRING CAUSAL IMPACT USING BAYESIAN STRUCTURAL TIME-SERIES MODELS [J].
Brodersen, Kay H. ;
Gallusser, Fabian ;
Koehler, Jim ;
Remy, Nicolas ;
Scott, Steven L. .
ANNALS OF APPLIED STATISTICS, 2015, 9 (01) :247-274
[7]   How Long Does Adaption Last for? An Update on the Psychological Impact of the Confinement in Portugal [J].
Costa, Ana Daniela ;
Fernandes, Afonso ;
Ferreira, Sonia ;
Couto, Beatriz ;
Machado-Sousa, Mafalda ;
Moreira, Pedro ;
Morgado, Pedro ;
Pico-Perez, Maria .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (04)
[8]   Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic [J].
Currie, Janet M. ;
Schnell, Molly K. ;
Schwandt, Hannes ;
Zhang, Jonathan .
JAMA NETWORK OPEN, 2021, 4 (04)
[9]   COVID-19 and the Invisible Damage [J].
de Melo, Renato Bessa ;
Tavares, Nuno Teixeira ;
Duarte, Raquel .
ACTA MEDICA PORTUGUESA, 2020, 33 (05) :293-294
[10]   Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications [J].
Downs, Callie G. ;
Varisco, Tyler J. ;
Bapat, Shweta S. ;
Shen, Chan ;
Thornton, J. Douglas .
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2021, 17 (01) :2005-2008